home / press / releases

Menu
  • Search all tables

releases: https://markharris.house.gov/media/press-releases/harris-statement-fdas-mifepristone-safety-study-update

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://markharris.house.gov/media/press-releases/harris-statement-fdas-mifepristone-safety-study-update Harris Statement on FDA’s Mifepristone Safety Study Update 2026-10-08 2026 2026-10 Republican House NC Mark Harris H001102 markharris.house.gov markharris https://markharris.house.gov/media/press-releases scraper WASHINGTON, D.C. — Today, Congressman Mark Harris (NC-08) released the following statement in response to the Food and Drug Administration’s court-ordered update on its mifepristone safety study: “Chemical abortions are unsafe for the mother and lethal for the baby. Further delays are unacceptable and will result in the deaths of an additional 90,000 unborn children in pro-life states. “We have a moral duty to protect the lives of the most vulnerable, and amid the continued absence of critical safeguards, Congress must pass my Teleabortion Prevention Act. My bill would crack down on mail-order abortions by requiring in-person medical care before, during, and after a chemical abortion.” ### 1 2026-10-09T11:42:00Z 2026-10-09T11:43:15Z
Powered by Datasette · Queries took 0.662ms · Data license: MIT · Data source: dwillis/congress-press